This is the official Google+ page for Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) is a leading global pharmaceutical company that delivers high-quality, patient-centric healthcare solutions to millions of patients every day.
Headquartered in Israel, Teva is the world’s largest generic medicines producer, leveraging its portfolio of more than 1,000 molecules to produce a wide range of generic products in nearly every therapeutic area. In specialty medicines, Teva has a world-leading position in innovative treatments for disorders of the central nervous system, including pain, as well as a strong portfolio of respiratory products. Teva integrates its generics and specialty capabilities in its global research and development division to create new ways of addressing unmet patient needs by combining drug development capabilities with devices, services and technologies.
Teva's net revenues in 2014 amounted to $20.3 billion. For more information, visit www.tevapharm.com
Note to Users: This page is intended to provide news and updates about our company, and Teva reserves the right to delete any comments that it considers to be inappropriate, abusive or spam.
Adverse events for any of our products should be reported to: Safety.AE@teva.co.il
Product-specific questions should be directed to Teva or Teva Group subsidiaries in your country. Contact details may be found here: http://www.tevapharm.com/en-US/Pages/Contact-Us.aspx
Learn more: http://rxabusesolutions.org
Teva colleagues in the UK brought a colorful Diwali celebration to co-workers at our Harlow site, observing the Hindu "Festival of Lights” and enriching our diverse community of employees through opportunities to share holiday customs and sweet delicacies with coworkers, and looking fabulous in traditional dress for the occasion. A Rangoli pattern welcomed employees in the main reception area as a symbol of good luck and welcoming to all.
"We have taken great steps towards changing Teva profoundly, in a way that further highlights what makes us unique in this industry, allows us to better serve patients and enables us to provide significant value for all of our stakeholders," said Erez Vigodman, Teva's President and CEO.
RBC, a leading Russian media group, compiled the first Women CEO rating. Notably, of the 500 leading companies in Russia, only 25 are headed by women, and four of those are in pharmaceuticals! This impressive result reflects the diverse opportunities the Russian pharma industry offers, and Teva is excited to be among those leading the way.